Ali Tavassoli, Ph.D.CSO, Curve Therapeutics at University of Southampton
Ali is Professor of Chemical Biology at the University of Southampton in the UK, and founder and CSO of Curve Therapeutics. Ali is also the president elect of the Royal Society of Chemistry's “Chemistry and Biology Interface Division” (2020-2023). Ali has previously served as the Chair of the RSC's Chemical Biology and Bioorganic Group (2012-2015). Ali has won a number of awards during his career, including the European Association for Chemical and Molecular Sciences' medal for European Young Chemist (in 2008) and the RSC’s Protein and Peptide Science Award (in 2017).